" class="no-js "lang="en-US"> Marie-Andrée Gamache - Medtech Alert
Saturday, July 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Marie-Andrée Gamache

Marie-Andrée Gamache

About Marie-Andrée Gamache

Related Story

Appointments

 Marie- Andrée Gamache Appointed Country President

Marie- Andrée Gamache Appointed Country President, Novartis Innovative Medicines, UK & Ireland

August 25 2022

Novartis UK is announcing that Marie-Andrée Gamache has been appointed to the role of Country […]

Diseases

 NICE Recommends Novartis’ Piqray ® (Alpelisib) as a Targeted Treatment for Thousands of Advanced Breast Cancer Patients | Pharmtech Focus

NICE Recommends Novartis’ Piqray ® (Alpelisib) as a Targeted Treatment for Thousands of Advanced Breast Cancer Patients

July 18 2022

Today Novartis Pharmaceuticals UK announces that the National Institute for Health and Care Excellence (NICE) […]

Diseases

 Thousands Of Patients To Benefit As NHS Marks 100th Fast-Tracked Cancer Drug | Pharmtech Focus

Thousands Of Patients To Benefit As NHS Marks 100th Fast-Tracked Cancer Drug

July 15 2022

Thousands of people a year with advanced breast cancer will benefit from a life-extending drug […]

Cardiovascular

 Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care | Pharmtech Focus

Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care

July 6 2022

Novartis Pharmaceuticals UK announces the launch of the Novartis Biome UK Heart Health Catalyst 2022, […]